"Immunohistochemistry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
| Descriptor ID |
D007150
|
| MeSH Number(s) |
E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
|
| Concept/Terms |
Immunolabeling Techniques- Immunolabeling Techniques
- Immunolabeling Technique
- Technique, Immunolabeling
- Techniques, Immunolabeling
- Immunolabeling Technics
- Immunolabeling Technic
- Technic, Immunolabeling
- Technics, Immunolabeling
Immunogold Techniques- Immunogold Techniques
- Immunogold Technique
- Technique, Immunogold
- Techniques, Immunogold
- Immunogold Technics
- Immunogold Technic
- Technic, Immunogold
- Technics, Immunogold
Immunogold-Silver Techniques- Immunogold-Silver Techniques
- Immunogold Silver Techniques
- Immunogold-Silver Technique
- Technique, Immunogold-Silver
- Techniques, Immunogold-Silver
- Immunogold-Silver Technics
- Immunogold Silver Technics
- Immunogold-Silver Technic
- Technic, Immunogold-Silver
- Technics, Immunogold-Silver
|
Below are MeSH descriptors whose meaning is more general than "Immunohistochemistry".
Below are MeSH descriptors whose meaning is more specific than "Immunohistochemistry".
This graph shows the total number of publications written about "Immunohistochemistry" by people in this website by year, and whether "Immunohistochemistry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 18 | 18 |
| 1995 | 0 | 24 | 24 |
| 1996 | 0 | 30 | 30 |
| 1997 | 2 | 35 | 37 |
| 1998 | 0 | 29 | 29 |
| 1999 | 0 | 36 | 36 |
| 2000 | 1 | 33 | 34 |
| 2001 | 0 | 48 | 48 |
| 2002 | 0 | 46 | 46 |
| 2003 | 0 | 57 | 57 |
| 2004 | 0 | 47 | 47 |
| 2005 | 0 | 68 | 68 |
| 2006 | 0 | 61 | 61 |
| 2007 | 0 | 55 | 55 |
| 2008 | 3 | 55 | 58 |
| 2009 | 0 | 68 | 68 |
| 2010 | 2 | 65 | 67 |
| 2011 | 2 | 50 | 52 |
| 2012 | 0 | 59 | 59 |
| 2013 | 1 | 54 | 55 |
| 2014 | 3 | 53 | 56 |
| 2015 | 2 | 41 | 43 |
| 2016 | 2 | 41 | 43 |
| 2017 | 4 | 37 | 41 |
| 2018 | 1 | 28 | 29 |
| 2019 | 4 | 26 | 30 |
| 2020 | 4 | 17 | 21 |
| 2021 | 1 | 21 | 22 |
| 2022 | 0 | 6 | 6 |
| 2023 | 1 | 3 | 4 |
| 2024 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunohistochemistry" by people in Profiles.
-
Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature. Hum Pathol. 2024 Nov; 153:105680.
-
Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2024 Nov 01; 148(11):1251-1271.
-
Unraveling the Membrane Topology of TMEM151A: A Step Towards Understanding its Cellular Role. J Mol Biol. 2024 Dec 01; 436(23):168834.
-
Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes. Virchows Arch. 2024 Sep; 485(3):535-546.
-
Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung. Cancer Cytopathol. 2024 Oct; 132(10):656-665.
-
Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis. Mod Pathol. 2024 Sep; 37(9):100543.
-
Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma. Cancer J. 2024 May-Jun 01; 30(3):133-139.
-
Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior. Am J Surg Pathol. 2024 Jul 01; 48(7):813-824.
-
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology. Am J Clin Pathol. 2023 09 01; 160(3):238-246.
-
Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores-Reply. JAMA Oncol. 2023 09 01; 9(9):1299-1300.